Navigation Links
Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel
Date:6/19/2013

Salt Lake City, UT (PRWEB) June 19, 2013

Ethigen announced today the US launch of their expanded BRCA1 and BRCA2 testing service, providing next-generation sequencing (NGS) and rearrangement analysis of both genes. Analysis is available individually, or as part of an expanded hereditary cancer panel, including full coverage of up to seventeen additional genes with known links to cancer risk: MLH1, MSH2, MSH6, APC, MUTYH (MYH), PTEN, TP53, CDK4, STK11, SMAD4, BMPR1A, CDH1, MET, FH, FLCN, PDGFRA, and KIT.

The expanded panel represents the most advanced and comprehensive hereditary cancer analysis in the market today. Genetics professionals may select BRCA analysis only, or select from any combination of the other seventeen available genes at no additional cost. This unique structure provides clinicians with the ability to tailor the breadth of analysis to the patient’s specific family history and desire for information.

“We’re entering a new era of testing for hereditary cancer risk, with better and more complete tests available at increasingly affordable price points,” said Eric M. Dyer, President of Ethigen, LLC. "Ethigen is thrilled to be leading the industry with the most comprehensive and rationally-priced BRCA testing solution available, enabling patients and their health care providers make the most informed, personalized decisions possible.”

Ethigen provides CLIA-certified NGS testing services for numerous genetic disorders, with a primary focus on the hereditary cancer syndromes including hereditary breast and ovarian cancer (HBOC), Lynch syndrome, and the varied polyposis syndromes. Founded in 2011, the company works exclusively with licensed genetics professionals.

“With these more inclusive tests, the need for specific training in the interpretation and reporting of potentially complex genetic results has never been more important. Ethigen strongly advocates for the involvement of a Certified Genetic Counselor, and requires their participation with every test we offer,” said Dyer. “We look forward to working in partnership with the genetic counseling community to better serve the multitudes of individuals who remain in need of appropriate counseling and testing for these common and highly manageable disorders.”

About Ethigen™

Ethigen is a privately-held, international provider of laboratory testing services, committed to ensuring a more informed and responsible future for genetic testing. Ethigen is driven by three guiding principles: to provide the most advanced, clinically relevant genetic testing solutions possible; to encourage more fair and rational pricing for genetic testing services; and to aggressively advocate for the critical role served by the Certified Genetic Counselor throughout the testing process.

Ethigen’s services are certified by the College of American Pathologists (CAP), Clinical Laboratories Improvement Act (CLIA), and Clinical Pathology Accreditation (CPA), with a primary emphasis on the hereditary cancer disorders affecting millions worldwide.

Ethigen seeks to always maintain an ethical awareness of the small but important role it plays in ensuring that genetic science is always used to advance the best interests of patients, genetics professionals, and the community at large. For more information, visit http://www.ethigen.net.

Media Contact:
Eric M. Dyer, President
edyer(at)ethigen(dot)net
(888) 578-7872
http://www.ethigen.net

Read the full story at http://www.prweb.com/releases/Ethigen/BRCA/prweb10843704.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation
2. Canabud.ca Launches Website and Provides link to new Canadian Marijuana for Medical Purposes Regulation
3. South Bay Vascular Center and Vein Institute Launches New Campaign to Promote Men’s Health During Men’s Health Month
4. Novant Health Vein Specialists Launches New Campaign to Promote Men’s Health During Men’s Health Month
5. Filtersfast.com Launches Spazazz Aromatherapy Spa & Bath Crystals
6. C8 Lawsuit News: Wright & Schulte LLC Launches C8 Facebook Page to Provide Up-to-Date Information On C8 Exposure and C8 Lawsuits in Ohio and West Virginia
7. GB HealthWatch Launches Gene-Based Weight Control eTool
8. Insect Shield® Launches Repellent Outdoor Blanket
9. Double PhD launches long duration assistance package
10. International Yoga Training School Launches At-Home Version of Hot Yoga
11. Renowned Rim Fitments Expert, SizeItUp Launches The Database Integrations for the 2012 Nissan GT-R
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... Benefits delivery trailblazer, Hodges-Mace, LLC, ... centralized benefits dashboard solving one of the top frustrations in employee benefits – ... first time, employees can access up-to-date information and account balances for all of ...
(Date:3/23/2017)... CO (PRWEB) , ... March 23, 2017 , ... ... serving the families and businesses of the greater Fort Collins area, has unveiled ... in their ongoing community involvement program. Donations to this worthy cause may now ...
(Date:3/23/2017)... ... 23, 2017 , ... ChenMed, a privately owned medical, management ... strategic executive team expansion needed to further optimize growth and performance. , “We ... Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and Donald Trexler ...
(Date:3/23/2017)... ... ... Inflow IQ & Inflownomics of Raleigh, NC introduce a powerful information access ... As experts in dangerous situations the Inflow IQ team can help people. Get ... clean & refreshing knowledge systems that enhance life. , Authentically enjoy ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March 2017, ... US Special Operations Command’s Patriot Award. The award was presented by the USSOCOM ... Dagger Foundation for its significant and enduring support to the command. , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... , March 23, 2017 ... ended the trading session at 5,821.64, up 0.48%; ... to finish at 20,661.30; and the S&P 500 ... broad based as six out of nine sectors ... has initiated reports coverage on the following Medical ...
(Date:3/23/2017)... March 23, 2017 ... Enterprises Limited, gibt die Ernennung von Stuart ... bietet seinen globalen Pharmazeutikkunden eine einmalige integrierte ... wichtige Rolle für das erfolgreiche Wachstum und ... Leiter wird Herr Needleman dafür verantwortlich sein, ...
Breaking Medicine Technology: